Safety and efficacy of90Yttrium-Ibritumomab-Tiuxetan for untreated follicular lymphoma patients. An Italian cooperative study-Reference-Cited by-同舟云学术

Safety and efficacy of90Yttrium-Ibritumomab-Tiuxetan for untreated follicular lymphoma patients. An Italian cooperative study

Published:2013-12-17 Issue:5 Volume:164 Page:710-716
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Ibatici Adalberto¹,Pica Gian Matteo¹,Nati Sandro¹,Vitolo Umberto²,Botto Barbara²,Ciochetto Chiara²,Petrini Mario³,Galimberti Sara³,Ciabatti Elena³,Orciuolo Enrico³,Zinzani Pier Luigi⁴,Cascavilla Nicola⁵,Guolo Fabio¹,Fraternali Orcioni Giulio⁶,Carella Angelo M.¹

Affiliation:

1. U.O. Ematologia 1; IRCCS AOU San Martino-IST; Genova Italy

2. Ematologia 2; A.O. San Giovanni Battista Hospital and University; Torino Italy

3. Divisione di Ematologia; A.O. Pisana Santa Chiara; Pisa Italy

4. Cattedra di Ematologia; Policlinico Sant'Orsola Malpighi; Bologna Italy

5. Divisione di Ematologia; Casa Sollievo della Sofferenza; San Giovanni Rotondo Italy

6. U.O. Anatomia Patologica; IRCCS AOU San Martino-IST; Genova Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12695/fullpdf

Reference23 articles.

1. Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation;Anderson;Blood,1984

2. An Intergroup randomised trial of rituximab versus a watch and wait strategy in patients with stage II, III, IV, asymptomatic, non-bulky follicular lymphoma (Grades 1, 2 and 3a). A preliminary analysis;Ardeshna;Blood,2010

3. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group;Cheson;Journal of Clinical Oncology,1999

4. Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy;Czuczman;Journal of Clinical Oncology,1999

5. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936;Dongen;Leukemia,2003

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radioligand Therapy in Lymphoma;PET Clinics;2024-10

2. Radioimmunotherapy;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

3. The asymptomatic follicular lymphoma (AFL) trial: single-agent rituximab immunotherapy versus 90Y-ibritumomab tiuxetan radioimmunotherapy (RIT) for patients with new, untreated follicular lymphoma;Leukemia & Lymphoma;2024-01-08

4. Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade Lymphomas;Clinical Lymphoma Myeloma and Leukemia;2023-04

5. Real World Long-term Follow-up Experience with Yttrium-90 ibritumomab tiuxetan in Previously Untreated Patients with Low-Grade Follicular Lymphoma and Marginal Zone Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2022-08